On Tuesday, March 20th, 2018, the Global Sepsis Alliance, jointly with EU Commissioner for Health and Food Safety, Vytenis Andriukaitis, will host the event 'Sepsis - The Most Preventable Cause of Death and Disability in Europe - A Call to EU Action' in Brussels, Belgium.
Mon, 10/22/2018 - 02:00 to Wed, 10/24/2018 - 02:00
This three-day, highly practical course, will cover all essential aspects of the Cost Benefit Analysis (CBA) of 2014-2020, in line with the European Commission Guide on CBA, published in December 2014. It will be conducted by experts from the European Commission and JASPERS – the lead author of the CBA Guide. It explains why CBA continues to be one of the most important tools in the programming period of 2014-2020 not only for beneficiaries of EU funds, but also for national and regional administrations in their decision-making process regarding investment projects.
Thu, 10/25/2018 - 02:00 to Fri, 10/26/2018 - 02:00
This course is a follow-up to the ‘CBA Why and How’ course and it explains in a very detailed and practical way how to successfully perform each element of a CBA, including the financial, economic, sensitivity and risk analysis of projects eligible under EU Funds in different sectors. It lays special emphasis on typical benefits and the techniques used most frequently to evaluate them in the programming period of 2014-2020.
Thu, 04/26/2018 - 02:00 to Fri, 04/27/2018 - 02:00
This two days Seminar will present the best Knowledge Management (KM) practices in Europe and demonstrate how to ensure a real transfer and retention of knowledge in public sector entities. We will discuss the stages for development of a conceptual KM framework, building up strategies and plans for implementing it at three moments: the knowledge capture of newcomers, the constant flux of knowledge throughout the organisation, and the knowledge retention exercise.
The current debate on the next EU Framework Programme for Research and Innovation (FP9) offers the opportunity to articulate a long-term vision for biomedical and health research, and to address current gaps in support of excellent science. Developing such a vision for Europe is important to make sure that future research will continue to improve citizens’ health and quality of life.
